Overview

Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
Children's Hospital Colorado
Treatments:
Colchicine
Criteria
- Advanced hepatic fibrosis or cirrhosis in children

- Not pregnant